Aclarion, Inc. (NASDAQ:ACONW) Sees Large Growth in Short Interest

Aclarion, Inc. (NASDAQ:ACONW) saw a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 138,906 shares, an increase of 5,197.7% from the July 15th total of 2,622 shares. Based on an average daily volume of 17,376 shares, the short-interest ratio is presently 8.0 days.

Aclarion Stock Down 13.6%

ACONW stock traded down $0.00 during mid-day trading on Tuesday, reaching $0.03. 9,638 shares of the stock traded hands, compared to its average volume of 23,458. The business has a 50-day moving average of $0.03 and a two-hundred day moving average of $0.03. Aclarion has a 52 week low of $0.02 and a 52 week high of $0.23.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.